Upload
alma
View
27
Download
0
Embed Size (px)
DESCRIPTION
Simulation study stability Oxytocics Michiel de Goeje. Study design. Simulation study of several products of several brands at several storage conditions Ergometrine injection Methylergometrine injection Oxytocine injection. Study design. Different brands 3 or 4 brands for each product - PowerPoint PPT Presentation
Citation preview
Simulation study stability OxytocicsMichiel de Goeje
- 2 -
Study design
Simulation study of several products of several brands at several storage conditions
Ergometrine injection
Methylergometrine injection
Oxytocine injection
- 3 -
Study design
Different brands•3 or 4 brands for each product
•2 batches of each brand
Different temperatures•2-8°C, RT(21°), 25°, 30°, 40°, 50°C
Different times•0; 0.5; 1; 2; 3; 6; 12; 24 months
- 4 -
Design
Influence of light
Manufacturing characteristics•pH, oxygen, antioxidants
Colour changes
- 5 -
Results and conclusion
Both Ergometrine as well as Methylergometrine are very sensitive to light.
- 6 -
Influence of light
Ergometrine
0
20
40
60
80
100
120
0 0.5 1 2 3 6 12 24
time (months)
acti
ve in
gre
die
nt
%
Lrm
Drm
- 7 -
Influence of light
Methylergometrine
0
20
40
60
80
100
120
0 0.5 1 2 3 6 12 24
time (months)
act
ive
ing
red
ien
t %
Lrm
Drm
- 8 -
Influence of light oxytocin
84
86
88
90
92
94
96
98
100
102
0 0.5 2 6 12 24
time (months)
act
ive in
gre
die
nt
(%)
D21
Lrm
- 9 -
Influence Temperature
Ergometrine
0
20
40
60
80
100
120
0 0.5 1 2 3 6 12 24
time (months)
acti
ve in
gre
die
nt
%D4-8
D21
Lrm
Drm
D25
D30
D40
D50
- 10 -
Influence Temperature
Methylergometrine
0
20
40
60
80
100
120
0 0,5 1 2 3 6 12 24
time (months)
acti
ve i
ng
red
ien
t %
D4-8
D21
Lrm
Drm
D25
D30
D40
D50
- 11 -
Influence Temperature oxytocin
0
20
40
60
80
100
120
0 0,5 2 6 12 24
time (months)
acti
ve i
ng
red
ien
t (%
) D4-8
D21
Lrm
D30
D40
D50
- 12 -
Difference in products
Average decrease in content after 1 year
Oxytocin is the most stable product
D4-8 D21 Lrm D25 D30
Ergometrine 5,1% 21% 91% 27% 31%
Methyl-ergometrine 3,7% 14% 91% 15% 18%
Oxytocin 0,0% 4,1% 7% 14%
- 13 -
Variability in stability of the different products
Relative Standard deviation in content after one year
D4-8 D21 Lrm D30
Ergometrine 6% 27% 87% 24%
Methylergmetrine 5% 15% NA 18%
Oxytocin 1.1% 1.5% 2.5% 3.8%
- 14 -
Colour changes
Both Ergometrine and Methylergometrine show discolouration if degradation is more then 10%.
Slight colour changes are not easy detectable in the field
Coloured injection should not be used !
- 15 -
•The stability of ergometrine and methylergometrine is sensitive to changes in manufacturing proces
•Filling under nitrogen needed
•Oxytocin is more predictable in behaviour
Design and manufacturing conditions
- 16 -
Stability current suppliers IDA
Simulation study D4-8 D21 Lrm D25 D30
Ergometrine 5% 21% 91% 27% 31%
Methylergometrine 4% 14% 91% 15% 18%
Oxytocin 1.4% 5% 7% 15%
Average decrease in content after 1 year (%)
Current suppliers D4-8 D21 D25
Ergometrine 2 % 19 %
Methylergometrine 5 %* 2,4 %
Oxytocin 2 % 4 % 4 %
* Stability from a different brand
- 17 -
Stability current suppliers IDA
Oxytocin Labeled storage temperature 2-8°C (cool).The shelflife at this temperature is 3 years.
Advice for shelflife IDA products at higher temperature
• at 25°C the shelflife is reduced to 1 years.• at 30°C the shelflife is reduced to 6 months.• at 40°C transport maximum 1 week.
- 18 -
Stability current suppliers IDA
Methylergometrine Labeled storage temperature 2-8°C or 25° depending on manufacturerThe shelflife at this temperature is 2 years.
Advice for shelflife IDA products at higher temperature (only for manufacturer Gland)
• at 25°C the shelflife is 2 years• at 30°C the shelflife is reduced to 1 year• at 40°C transport maximum 4 weeks
- 19 -
Stability current suppliers IDA
ergometrine Labeled storage temperature 2-8°C The shelflife at this temperature is 2 years.
Advice for shelflife IDA products at higher temperature
• at 25°C the shelflife is reduced to 6 months• at 40°C transport maximum 2 weeks
- 20 -
Pharmacopoeial requirements on sensitivity to light
BP2005 USP26
Ergometrineprotect from light
in a light resistant container
Methyl-ergmetrine
Not included
in a light resistant container
OxytocinNo require-ments
No require- ments
- 21 -
On storage temperature
Pharmacopoeial requirements
BP2005 USP26
Ergometrine 2° to 8 °C 8-15 ºC
Methyl-ergometrine Not included No requirements
Oxytocin No requirements 2° to 8 °C
- 22 -
Quality assurance
Product should be procured through a reliable source.
BP assay is not specific for degradation products and therefore release and stability studies should be based on analysis by validated HPLC methods
- 23 -
Protect from light
Store refridgerated.
Manufacturer should be able to guarantee 2 years shelflife at refridgerated conditions.
Storage outside refridgeration (up to 30°C) may limit the shelflife to less then half year but is dependent on manufacturer.
Do not use coloured products.
Recommendation on storage ergometrine
- 24 -
Protect from light
Store refridgerated, although some brand may guarantee it up to 25°C
Manufacturer should be able to guarantee 2-3 years shelflife at refridgerated conditions.
Storage outside refridgeration may limit the shelflife to a year but is dependent on manufacturer.
Do not use coloured products.
Recommendation on storage methyl ergometrine
- 25 -
Recommended to store refridgerated.
It is expected to remain of sufficient quality if stored below 21°C up to 2 years.
When stored up to 30°C a loss of 15% in one year is expected. Thus shelflife is then limited to 6 months only.
Recommendation on storage Oxytocin
- 26 -
Simulation study stability Oxytocics
Stability data simulation study are based on study performed in collaboration with WHO WHO/DAP/93.6
Michiel de GoejePharmacist IDA Foundation